ArticleClinical and molecular hepatology2024

Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on "Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?"

Dorothy Cheuk-Yan Yiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.